Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study

Abstract

Previous investigations have shown that changes in total prostate volume (TPV) are highly variable among aging men, and a considerable proportion of aging men have a stable or decreasing prostate size. Although there is an abundance of literature describing prostatic enlargement in association with benign prostatic hyperplasia, less is known about the appropriate age cut-off points for TPV growth rate. In this community-based cohort study, TPV was examined once a year in men who had consecutive health checkup, during a follow-up of 4 years. A total of 5058 men (age 18–92 years old) were included. We applied multiple regression analyses to estimate the correlation between TPV growth rate and age. Overall, 3232 (63.9%) men had prostate growth, and 1826 (36.1%) had a stable or decreased TPV during the study period. The TPV growth rate was correlated negatively with baseline TPV (r=–0.32, P<0.001). Among 2620 men with baseline TPV <15 cm³, the TPV growth rate increased with age (β=0.98, 95% CI: 0.77%–1.18%) only up to 53 years old. Among 2188 men with baseline TPV of 15–33.6 cm³, the TPV growth rate increased with age (β=0.84, 95% CI, 0.66%–1.01%) only up to 61 years old after adjusting for factors of hypertension, obesity, baseline TPV, diabetes mellitus and dyslipidemia. In this longitudinal study, the TPV growth rate increased negatively with baseline TPV, only extending to a certain age and not beyond. Further research is needed to identify the mechanism underlying such differences in prostate growth.

Keywords

total prostate volume / total prostate volume growth rate / prostatic hyperplasia / aging men

References

[1] BoschJL, TillingK, BohnenAM, et al. . Establishing normal reference ranges for prostate volume change with age in the population-based Krimpen-study: prediction of future prostate volume in individual men. Prostate, 2007, 67(16): 1816-1824 PMID: 17935157

[2] BerrySJ, CoffeyDS, WalshPC, et al. . The development of human benign prostatic hyperplasia with age. J Urol, 1984, 132(3): 474-479 PMID: 6206240

[3] WeiJT, CalhounE, JacobsenSJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol, 2005, 173(4): 1256-1261 PMID: 15758764

[4] TerrisMK, StameyTA. Determination of prostate volume by transrectal ultrasound. J Urol, 1991, 145(5): 984-987 PMID: 2016815

[5] HammarstenJ, HogstedtB. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol, 2001, 39(2): 151-158 PMID: 11223674

[6] HammarstenJ, HogstedtB. Calculated fast-growing benign prostatic hyperplasia—a risk factor for developing clinical prostate cancer. Scand J Urol Nephrol, 2002, 36(5): 330-338 PMID: 12487736

[7] HammarstenJ, HogstedtB. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press, 2004, 13(1): 47-55 PMID: 15083641

[8] XiaSJ, XuXX, TengJB, et al. . Characteristic pattern of human prostatic growth with age. Asian J Androl, 2002, 4(4): 269-271 PMID: 12508127

[9] LoebS, KettermannA, CarterHB, et al. . Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging. J Urol, 2009, 182(4): 1458-1462 PMID: 19683305 PMCID: 5003410

[10] RoehrbornCG, McConnellJD, LieberM, et al. . Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology, 1999, 53(3): 473-480

[11] ChenXL, YangQF, LiuCF, et al. . Correlation between metabolic syndrome and benign prostatic hyperplasia in senior patients. Chin J Geriatr, 2011, 30: 562-565

[12] JeongCW, ParkHK, HongSK, et al. . Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy. Urol Int, 2008, 81(2): 179-185 PMID: 18758216

[13] OzdenC, OzdalOL, UrganciogluG, et al. . The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007, 51(1): 199-203 PMID: 16806666

[14] WilliamsAM, SimonI, LandisPK, et al. . Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl, 1999, 20(4): 474-480 PMID: 10452590

[15] RhodesT, GirmanCJ, JacobsenSJ, et al. . Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol, 1999, 161(4): 1174-1179 PMID: 10081864

[16] ZhangSJ, QianHN, ZhaoY, et al. . Relationship between age and prostate size. Asian J Androl, 2013, 15(1): 116-120 PMID: 23223031

[17] TempanyCM, PartinAW, ZerhouniEA, et al. . The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate, 1993, 22(1): 39-42 PMID: 7678931

[18] TsukamotoT, MasumoriN, RahmanM, et al. . Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally. Int J Urol, 2007, 14(4): 321-324 PMID: 17470162

[19] WilliamsAM, SimonI, LandisPK, et al. . Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl, 1999, 20(4): 474-480 PMID: 10452590

[20] RahmouniA, YangA, TempanyCM, et al. . Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr, 1992, 16(6): 935-940 PMID: 1385499